4.5 Article

Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus:: Identification of a new native nAChR subtype α3β2(α5 or β3) enriched in retinocollicular afferents

Journal

MOLECULAR PHARMACOLOGY
Volume 68, Issue 4, Pages 1162-1171

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.105.015925

Keywords

-

Funding

  1. NIDA NIH HHS [DA019655, R21 DA019655, R01 DA012242, DA12242] Funding Source: Medline

Ask authors/readers for more resources

The activation of neuronal nicotinic acetylcholine receptors (nAChRs) has been implicated in the activity-dependent development and plasticity of retina and the refinement of retinal projections. Pharmacological and functional studies have also indicated that different presynaptic nAChRs can have a modulatory function in retinotectal synapses. We biochemically and pharmacologically identified the multiple nAChR subtypes expressed on retinal afferents of the superior colliculus (SC) and lateral geniculate nucleus (LGN). We found that the alpha 6 beta 2* and alpha 4(non alpha 6) beta 2* nAChRs are the major receptor populations expressed in both SC and LGN. In addition, the LGN contains two minor populations of alpha 2 alpha 6 beta 2* and alpha 3 beta 2* subtypes, whereas the SC contains a relatively large population of a new native subtype, the alpha 3 beta 2(alpha 5/beta 3) nAChR. This subtype binds the alpha-conotoxin MII with an affinity 50 times lower than that of the native alpha 6 beta 2* subtype. Studies of tissues obtained from eye-enucleated animals allowed the identification of nAChRs expressed by retinal afferents: in SC alpha 6 beta 2*, alpha 4 alpha 6 beta 2*, and alpha 3 beta 2* (approximately 45, 35, and 20%, respectively), in LGN, alpha 4 alpha 6 beta 2*, alpha 6 beta 2*, alpha 4 beta 2*, alpha 2 alpha 6 beta 2*, and alpha 3 beta 2* ( approximately 40, 30, 20, 5, and 5%, respectively). In both regions, more than 50% of nAChRs were not expressed by retinal afferents and belonged to the alpha 4 beta 2* (90%) or alpha 4 alpha 5 beta 2* (10%) subtypes. Moreover, studies of the SC tissues obtained from wild-type and alpha 4, alpha 6, and beta 3 knockout mice confirmed and extended the data obtained in rat tissue and allowed a comprehensive dissection of the composition of nAChR subtypes present in this retinorecipient area.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available